Mark J. Alles - May 24, 2021 Form 3 Insider Report for Turning Point Therapeutics, Inc. (TPTX)

Role
Director
Signature
/s/ Annette North, Attorney-in-Fact
Stock symbol
TPTX
Transactions as of
May 24, 2021
Transactions value $
$0
Form type
3
Date filed
5/26/2021, 04:46 PM
Next filing
Jun 4, 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.